Simplify the Management of Antithrombotics for Valvular Heart Disease
August 2017
We're getting questions about managing antithrombotics in patients with valvular heart disease...due to recent Am Heart Assn guidelines.
Who needs an antithrombotic? Continue to use an anticoagulant for most patients with a prosthetic heart valve.
Antiplatelet meds...such as clopidogrel for 6 months plus lifelong aspirin 81 mg/day...are an alternative for patients with transcatheter aortic valve replacement (TAVR). TAVR is similar to a cardiac stent...a new valve is placed with a catheter, which "takes over" for the old one.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote